| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Protokinetix, Inc. (PKTX) has 0 insiders with recent SEC Form 4 filings, including 11 buys and 4 sells. PKTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2022 | Smith Clarence Edward | President &CEO | Buy | 2,520,000 | $0.03 | $63,000.00 | +6.7% | |
| Sep 29, 2022 | Smith Clarence Edward | President &CEO | Buy | 3,333,333 | $0.03 | $99,999.99 | +9.7% | |
| Jul 11, 2022 | Smith Clarence Edward | President &CEO | Buy | 2,666,667 | $0.03 | $80,000.01 | +8.4% | |
| May 16, 2022 | Guzzetta Michael Richard | CFO | Buy | 10,000 | $0.05 | $490.00 | +1.4% | |
| Mar 30, 2022 | Smith Clarence Edward | President &CEO | Buy | 600,000 | $0.05 | $30,000.00 | +1.9% | |
| Mar 18, 2022 | Smith Clarence Edward | President &CEO | Buy | 1,000,000 | $0.05 | $50,000.00 | +3.3% | |
| Dec 22, 2021 | Smith Clarence Edward | President &CEO | Buy | 833,333 | $0.06 | $49,999.98 | +2.9% | |
| Sep 1, 2021 | Guzzetta Michael Richard | CFO | Buy | 5,000 | $0.13 | $650.00 | +0.2% | |
| Apr 27, 2021 | Guzzetta Michael Richard | CFO | Sale+OE | 27,500 | $0.23 | $6,236.50 | -1.0% | |
| Jan 12, 2021 | Smith Clarence Edward | President &CEO | Buy | 142,857 | $0.07 | $9,999.99 | +0.5% |